Valuation Mesa Laboratories, Inc.
Stocks
MLAB
US59064R1095
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.54 USD | +1.10% |
|
+11.74% | +34.45% |
Company Valuation: Mesa Laboratories, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,337 | 934.1 | 591.9 | 644.8 | 488.5 | 576.7 | - |
| Change | - | -30.14% | -36.64% | 8.93% | -24.23% | 18.06% | - |
| Enterprise Value (EV) | 1,506 | 1,084 | 591.9 | 644.8 | 488.5 | 576.7 | 576.7 |
| Change | - | -27.99% | -45.42% | 8.93% | -24.23% | 18.06% | 0% |
| P/E | 728x | 1,028x | -2.32x | -330x | 73.1x | 77.4x | 49.1x |
| PBR | 3.41x | 2.38x | 4.07x | 4.05x | 2.62x | 2.81x | 2.6x |
| PEG | - | -20x | 0x | 3.3x | -0x | 6.2x | 0.9x |
| Capitalization / Revenue | 7.25x | 4.26x | 2.74x | 2.68x | 1.96x | 2.23x | 2.12x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.23x | 2.12x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 9.13x | 8.6x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 8.78x | 8.19x |
| EV / FCF | 0x | 0x | 0x | 0x | 0x | 14.4x | 13x |
| FCF Yield | 2.6% | 2.51% | 7.02% | 6.6% | 8.1% | 6.94% | 7.68% |
| Dividend per Share 2 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 | 0.64 |
| Rate of return | 0.25% | 0.37% | 0.58% | 0.54% | 0.72% | 0.61% | 0.61% |
| EPS 2 | 0.35 | 0.17 | -47.2 | -0.36 | 1.21 | 1.36 | 2.143 |
| Distribution rate | 183% | 376% | -1.36% | -178% | 52.9% | 47.1% | 29.9% |
| Net sales 1 | 184.3 | 219.1 | 216.2 | 241 | 249.1 | 259.2 | 272.2 |
| EBITDA 1 | 41.16 | 49.68 | 50.5 | 56.74 | 63.49 | 63.2 | 67.1 |
| EBIT 1 | 37.9 | 45.82 | 50.5 | 51.36 | 58.23 | 65.7 | 70.4 |
| Net income 1 | 1.871 | 0.93 | -254.2 | -1.974 | 6.712 | 7.567 | 12.13 |
| Net Debt | 169 | 150.4 | - | - | - | - | - |
| Reference price 2 | 254.88 | 174.73 | 109.73 | 118.66 | 88.42 | 105.33 | 105.33 |
| Nbr of stocks (in thousands) | 5,246 | 5,346 | 5,394 | 5,434 | 5,525 | 5,525 | - |
| Announcement Date | 5/31/22 | 5/25/23 | 6/5/24 | 5/28/25 | 5/27/26 | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 76.76x | - | - | 0.61% | 577M | ||
| 22.8x | 3.43x | 12.87x | 2.76% | 161B | ||
| 17.95x | 3.16x | 11.13x | 3.74% | 101B | ||
| 15.86x | 0.18x | 11.37x | 0.82% | 56.12B | ||
| 32.74x | 7.95x | 20.8x | 1.23% | 53.35B | ||
| 38.1x | 3.02x | 10.38x | 2.52% | 42.13B | ||
| 39.95x | 1.44x | 12.67x | 0.2% | 35.29B | ||
| 28.13x | 5.01x | 15.96x | -.--% | 26.57B | ||
| 43.35x | 7.52x | 27.13x | 0.25% | 25.79B | ||
| 23.36x | 3.42x | 12.28x | 1.24% | 20.69B | ||
| Average | 33.90x | 3.90x | 14.96x | 1.34% | 52.25B | |
| Weighted average by Cap. | 25.89x | 3.60x | 13.80x | 2.07% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- MLAB Stock
- Valuation Mesa Laboratories, Inc.
Select your edition
All financial news and data tailored to specific country editions
















